Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.6K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous cytomegalovirus infection: a case report.

Skin health and disease·2026
Same author

Is CMV PCR Monitoring Necessary for Hematological Malignancy During Chemotherapy? A Prospective Single-Center Study.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2026
Same author

Rifaximin Versus Levofloxacin: A Comparative Analysis of Prophylactic Efficacy in Allogeneic Stem Cell Transplantation.

Transplantation proceedings·2026
Same author

Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2026
Same author

Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT.

Bone marrow transplantation·2026
Same author

Antiviral drug resistance in cytomegalovirus complicating hematopoietic stem cell transplantation: prevalence, genotypic analysis and novel <i>UL97/UL54</i> variants.

Journal of chemotherapy (Florence, Italy)·2026

Related Experiment Video

Updated: Apr 10, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

2.1K

Peripheral blood stem cell mobilization failure.

Fatih Kurnaz1, Leylagül Kaynar2

  • 1Hematology Department, Harran University Medical School, Yenişehir Campus, Sanliurfa 63000, Turkey.

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|June 16, 2015
PubMed
Summary
This summary is machine-generated.

Autologous hematopoietic stem cell transplantation (HSCT) relies on successful stem cell mobilization. Failure to mobilize adequate CD34+ cells can impede engraftment, impacting treatment success.

Keywords:
Hematopoietic stem cell transplantationMobilization failurePeripheral stem cell mobilization

More Related Videos

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
12:03

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

27.6K
Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors
09:45

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Published on: January 1, 2017

11.6K

Related Experiment Videos

Last Updated: Apr 10, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

2.1K
Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
12:03

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

27.6K
Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors
09:45

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Published on: January 1, 2017

11.6K

Area of Science:

  • Hematology
  • Oncology
  • Stem Cell Biology

Background:

  • Autologous hematopoietic stem cell transplantation (HSCT) is a critical treatment for hematological malignancies and some solid tumors.
  • Successful engraftment post-HSCT depends on mobilizing sufficient hematopoietic stem cells (HSCs).
  • Mobilization of CD34+ cells into circulation is achieved using granulocyte-colony stimulating factor ± chemotherapy.

Purpose of the Study:

  • To summarize the factors contributing to peripheral stem cell mobilization failure in patients undergoing autologous HSCT.
  • To identify key reasons why mobilization of hematopoietic stem cells may be insufficient for successful engraftment.

Main Methods:

  • Review and synthesis of existing literature on stem cell mobilization.
  • Analysis of factors influencing the efficacy of mobilization protocols.
  • Identification of patient-specific and treatment-related variables impacting stem cell yield.

Main Results:

  • Stem cell mobilization failure is defined by a CD34+ cell count below 2 × 10^6 cells/kg, crucial for platelet engraftment.
  • Prior chemotherapy (e.g., fludarabine, melphalan, lenalidomide) and radiotherapy are significant factors affecting mobilization.
  • Other influencing factors include patient age, disease type, and bone marrow cellularity.

Conclusions:

  • Understanding the causes of stem cell mobilization failure is essential for optimizing autologous HSCT outcomes.
  • Identifying and mitigating factors that lead to mobilization failure can improve engraftment rates.
  • Further research may focus on novel strategies to enhance stem cell mobilization in challenging patient populations.